IPH.PA Stock Forecast & Price Target
IPH.PA Stock
Price Forecast
The average stock forecast for
Innate Pharma SA (IPH.PA) in the next 12 months is 5.46 EUR. This price target corresponds to an upside
of
206.92%. The range of stock forecasts for IPH.PA is 4.54 - 6.51 EUR.
Based on the ratings of 8 analysts, the consensus recommendation for IPH.PA is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (EUR) |
4.54 |
5.46 |
5.46 |
6.51 |
| Upside |
155.62% |
206.92% |
206.92% |
266.14% |
Recommendation Trends
The latest consensus rating for IPH.PA is "BUY". This is the average
recommendation of 8 analysts: 0 strong sell,
0 sell, 1 hold, 5 buy, 2 strong buy. In the previous period, 8 analysts also majorly recommmended
"BUY" for IPH.PA.
IPH.PA Financial Stock
Forecast
Revenue This Year
from 2.79M
Revenue Next Year
from 10.60M